CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy

International Journal of Hematology

Volumn 88, Issue 3, 2008, Pages 311-320

  Watanabe, Kazue ^a   Suzuki, Susumu ^c   Kamei, Michi ^b,d   Toji, Shingo ^a   Kawase, Takakazu ^b   Takahashi, Toshitada ^b   Kuzushima, Kiyotaka ^b,e   Akatsuka, Yoshiki ^b  

^a Medical & Biological Laboratories Co Ltd   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c T Cell Technologies Inc   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adoptive transfer; CD137; Cytotoxic T lymphocyte; Sorting

Indexed keywords

CD137 ANTIGEN; CYTOMEGALOVIRUS ANTIGEN PP65; EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; HLA A24 ANTIGEN; TETRAMER;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL ISOLATION; CELL SELECTION; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; TECHNIQUE; UPREGULATION;

ADOPTIVE TRANSFER; ANTIGENS, CD137; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL SEPARATION; CELLS, CULTURED; HUMANS; IMMEDIATE-EARLY PROTEINS; PHOSPHOPROTEINS; TRANS-ACTIVATORS; VIRAL MATRIX PROTEINS;

EID: 60049085293     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0134-z     Document Type: Article

References (21)

1. JA Fishman V Emery R Freeman 2007 Cytomegalovirus in transplantation- challenging the status quo Clin Transplant 21 149 58
2. V Ganne N Siddiqi B Kamaplath 2003 Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder Clin Transplant 17 417 22
3. S Gottschalk HE Heslop CM Rooney 2005 Adoptive immunotherapy for EBV-associated malignancies Leuk Lymphoma 46 1 10
4. EA Walter PD Greenberg MJ Gilbert 1995 Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor N Engl J Med 333 1038 44
5. HE Heslop CY Ng C Li 1996 Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes Nat Med 2 551 5
6. B Savoldo MH Huls Z Liu 2002 Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection Blood 100 4059 66
7. EB Papadopoulos M Ladanyi D Emanuel 1994 Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation N Engl J Med 330 1185 91
8. SR Riddell M Bleakley T Nishida C Berger EH Warren 2006 Adoptive transfer of allogeneic antigen-specific T cells Biol Blood Marrow Transplant 12 9 12
9. V Rubio TB Stuge N Singh 2003 Ex vivo identification, isolation and analysis of tumor-cytolytic T cells Nat Med 9 1377 82
10. MR Betts JM Brenchley DA Price 2003 Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation J Immunol Methods 281 65 78
11. H Brosterhus S Brings H Leyendeckers 1999 Enrichment and detection of live antigen-specific CD4(+) and CD8(+) T cells based on cytokine secretion Eur J Immunol 29 4053 9
12. M Wolfl J Kuball WY Ho 2007 Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities Blood 110 201 10
13. S Baumann A Krueger S Kirchhoff PH Krammer 2002 Regulation of T cell apoptosis during the immune response Curr Mol Med 2 257 72
14. TH Watts 2005 TNF/TNFR family members in costimulation of T cell responses Annu Rev Immunol 23 23 68
15. T Wen J Bukczynski TH Watts 2002 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function J Immunol 168 4897 906
16. TC Wehler M Nonn B Brandt 2007 Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines Blood 109 365 73
17. M Frentsch O Arbach D Kirchhoff 2005 Direct access to CD4+ T cells specific for defined antigens according to CD154 expression Nat Med 11 1118 24
18. L Sabbagh SM Kaech M Bourbonniere 2004 The selective increase in caspase-3 expression in effector but not memory T cells allows susceptibility to apoptosis J Immunol 173 5425 33
19. SR Burrows A Suhrbier R Khanna DJ Moss 1992 Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing Immunology 76 174 5
20. L Gattinoni CA Klebanoff DC Palmer 2005 Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells J Clin Invest 115 1616 26
21. A Diab AD Cohen O Alpdogan MA Perales 2005 IL-15: targeting CD8+ T cells for immunotherapy Cytotherapy 7 23 35